Bausch & Lomb today announced the worldwide launch of a new accommodating intraocular lens (IOL) with aspheric optics for use in cataract surgery.
The new IOL, called Crystalens AO, is designed to be free of spherical aberration that affects other IOLs and thereby produce sharper vision after cataract surgery. The announcement follows recent FDA approval of the Crystalens AO for use by cataract surgeons in the United States.
The aspheric optical surfaces of Crystalens AO are designed to improve retinal image quality without compromising depth of field, and therefore the new IOL provides higher quality distance and intermediate vision than other IOLs, according to the company.
“The Crystalens AO has zero spherical aberration, and the combination of the Crystalens platform and AO optics work together to enhance depth of field,” says Andy Corley, president of Bausch & Lomb’s global surgical division in a press release issued today by the company.
The Crystalens AO is the latest addition to the Crystalens line of accommodating IOLs produced by Bausch & Lomb, joining the Crystalens HD and the Crystalens Five-O. Currently, Crystalens is the only brand of accommodating IOL that is FDA-approved for use in cataract surgery performed in the United States.
Unlike conventional IOLs, the optical portion of accommodating IOLs can move slightly within the eye in response to focusing effort, to improve not only distance vision, but intermediate and near vision as well, reducing the need for reading glasses after cataract surgery.
Accommodating IOLs are a premium intraocular lens and therefore will increase your cataract surgery cost.
More information about Crystalens accommodating IOLs is available on Bausch & Lomb’s Crystalens website or by calling the company at 1-877-SEE BETTER.
Tags: accommodating IOL, Bausch & Lomb, Crystalens, intraocular lenses, IOLs